Bullseye Asset Management LLC Invitae Corp Transaction History

Bullseye Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	BUY	$14.7 - $28.67 $65,385 - $127,524	4,448 Added 14.54%	35,045 $535,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $117,879 - $162,926	4,849 Added 18.83%	30,597 $870,000
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $16,456 - $24,165	-421 Reduced 1.61%	25,748 $1.08 Million
Q3 2020 Nov 12, 2020	SELL	$28.43 - $44.67 $881 - $1,384	-31 Reduced 0.12%	26,169 $1.13 Million
Q2 2020 Aug 11, 2020	BUY	$11.71 - $30.29 $63,257 - $163,626	5,402 Added 25.97%	26,200 $793,000
Q1 2020 May 08, 2020	BUY	$7.64 - $27.5 $75,169 - $270,572	9,839 Added 89.78%	20,798 $284,000
Q4 2019 Feb 18, 2020	BUY	$15.02 - $20.57 $164,604 - $225,426	10,959 New	10,959 $177,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bullseye Asset Management LLC with notifications on news.